| abstract |
(57) A vaccine formulation for a cat comprising at least three polynucleotide vaccine valencies, wherein each polynucleotide vaccine valency comprises a gene for one feline pathogen valency that can be expressed in vivo in a host cell. Plasmids. Each valency is selected from the group consisting of feline leukemia virus, panleukopenia virus, infectious peritonitis virus, nasal cold virus, calicivirosis virus, feline immunodeficiency virus, and optionally also rabies virus. For each valency, the plasmid is env and gag for feline leukemia, VP2 for panleukopenia, modified S, M and N for infectious peritonitis virus, gB and gD for nasal cold, calicivirosis For capsid, env and gag / pro for feline immunodeficiency, and one or more genes selected from the group consisting of G for rabies. |